Published in Circulation on December 27, 2006
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ (2009) 3.83
Effect of exercise on 24-month weight loss maintenance in overweight women. Arch Intern Med (2008) 3.61
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord (2010) 2.19
Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care (2010) 1.58
The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr (2011) 1.58
Correlates of dietary intake in youth with diabetes: results from the SEARCH for diabetes in youth study. J Nutr Educ Behav (2011) 1.56
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.56
Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol (2010) 1.52
The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens (2013) 1.50
A growing disparity in diabetes-related mortality U.S. trends, 1989-2005. Am J Prev Med (2008) 1.44
Socio-medical Characteristics of Coronary Disease in Bosnia and Herzegovina and the World. Mater Sociomed (2011) 1.41
Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant (2010) 1.32
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ (2016) 1.30
Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes (2013) 1.29
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.22
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups. Circulation (2012) 1.19
Racial/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes. Diabetes Care (2011) 1.18
Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. J Mol Cell Cardiol (2008) 1.15
The cardiovascular effects of GLP-1 receptor agonists. Cardiovasc Ther (2010) 1.12
Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord (2010) 1.11
Prognostic value of coronary computed tomographic angiography in diabetic patients without known coronary artery disease. Diabetes Care (2010) 1.11
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus. Postgrad Med (2009) 1.08
Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol (2011) 1.08
Aspirin resistance in patients with type II diabetes mellitus. Ups J Med Sci (2013) 1.08
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study. Cardiovasc Diabetol (2010) 1.04
Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care (2013) 1.04
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol (2009) 1.04
Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc (2012) 1.04
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. J Hypertens (2010) 1.04
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J Hypertens (2008) 1.03
The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovasc Diabetol (2010) 1.03
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. Br J Pharmacol (2012) 1.02
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2012) 1.01
Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health (2008) 1.01
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther (2009) 0.98
Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status. PLoS One (2014) 0.98
Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol (2010) 0.97
Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes. Diabet Med (2011) 0.96
The role of aspirin in the prevention of cardiovascular disease. Clin Med Res (2014) 0.94
Heritability and coefficient of genetic variation analyses of phenotypic traits provide strong basis for high-resolution QTL mapping in the Collaborative Cross mouse genetic reference population. Mamm Genome (2014) 0.94
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS One (2012) 0.94
Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis. Cardiovasc Diabetol (2009) 0.93
Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ Res (2014) 0.92
Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease. Diabetes Care (2011) 0.92
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study. Diabetes Care (2009) 0.92
Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study. BMC Public Health (2010) 0.91
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing. Vasc Health Risk Manag (2008) 0.91
Physical activity and reported barriers to activity among type 2 diabetic patients in the United arab emirates. Rev Diabet Stud (2009) 0.89
Documentation of body mass index and control of associated risk factors in a large primary care network. BMC Health Serv Res (2009) 0.89
Should all diabetic patients be treated with a statin? Diabetes Care (2009) 0.89
Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data. Circulation (2010) 0.89
Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006. Open Cardiovasc Med J (2009) 0.89
NOX4 pathway as a source of selective insulin resistance and responsiveness. Arterioscler Thromb Vasc Biol (2012) 0.88
Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury. Cardiovasc Diabetol (2012) 0.88
A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose. Metabolism (2011) 0.88
Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol (2012) 0.88
Treatment Intensification for Hypertension in US Ambulatory Medical Care. J Am Heart Assoc (2016) 0.87
Influence of type 2 diabetes on symbolic analysis and complexity of heart rate variability in men. Diabetol Metab Syndr (2014) 0.87
Antidiabetic agents and cardiovascular risk in type 2 diabetes. Nat Rev Endocrinol (2009) 0.86
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract (2009) 0.86
The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus. J Am Coll Cardiol (2015) 0.85
Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry. Cardiovasc Diabetol (2015) 0.85
Diabetes, hypertension, and outcome studies: overview 2010. Diabetes Care (2011) 0.84
National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark. Front Pharmacol (2010) 0.84
Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study. BMC Endocr Disord (2012) 0.84
Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter study. PLoS One (2013) 0.84
Preventing and treating foot complications associated with diabetes mellitus. Nat Rev Endocrinol (2015) 0.83
Are adults diagnosed with diabetes achieving the American Diabetes Association clinical practice recommendations? P R Health Sci J (2012) 0.83
Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol (2011) 0.83
Diabetes: Which risk engines should be used to assess patients with diabetes? Nat Rev Endocrinol (2009) 0.83
Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients. Cardiovasc Diabetol (2013) 0.83
Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis (2013) 0.83
Cardiac health: primary prevention of heart disease in women. Nurs Clin North Am (2009) 0.82
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes. Australas Med J (2014) 0.82
Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. Am Health Drug Benefits (2013) 0.81
The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities. Exp Diabetes Res (2012) 0.81
Treatment approaches for diabetes and dyslipidemia. Horm Res Paediatr (2011) 0.81
Diabetes as an independent predictor of high atherosclerotic burden assessed by coronary computed tomography angiography: the coronary artery disease equivalent revisited. Int J Cardiovasc Imaging (2012) 0.81
Dietary Sodium Intake in People with Diabetes in Korea: The Korean National Health and Nutrition Examination Survey for 2008 to 2010. Diabetes Metab J (2016) 0.81
Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event. PLoS One (2008) 0.80
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. Front Immunol (2015) 0.80
Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep (2012) 0.80
Missed opportunities for providing low-fat dietary advice to people with diabetes. Prev Chronic Dis (2012) 0.80
Age-related differences in glycaemic control in diabetes. Diabetologia (2013) 0.80
Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training. Vascul Pharmacol (2012) 0.80
Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care. Cardiovasc Diabetol (2012) 0.80
Combination therapy of statins and fibrates in the management of cardiovascular risk. Curr Opin Lipidol (2009) 0.80
Prevalence of obesity in patients with type 2 diabetes mellitus in yemen. Int J Endocrinol Metab (2014) 0.79
Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients. Diabetes Care (2012) 0.79
Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspective. Am J Public Health (2011) 0.79
A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy. Diabetol Metab Syndr (2015) 0.79
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus. Kidney Int Suppl (2011) (2012) 0.79
Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice. Cardiovasc Diabetol (2013) 0.79
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2005) 11.91
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med (2004) 10.29
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Effect of ramipril on the incidence of diabetes. N Engl J Med (2006) 9.69
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med (2005) 9.43
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 8.92
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Diagnosis and classification of diabetes mellitus. Diabetes Care (2004) 8.66
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Diagnosis and classification of diabetes mellitus. Diabetes Care (2014) 8.37
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab (2004) 8.36
Diagnosis and classification of diabetes mellitus. Diabetes Care (2008) 8.16
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab (2008) 7.97
Diagnosis and classification of diabetes mellitus. Diabetes Care (2006) 7.91
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 7.66
Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 7.61
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 6.01
Standards of medical care in diabetes. Diabetes Care (2005) 5.98
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med (2013) 5.87
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Gestational diabetes mellitus. Diabetes Care (2004) 5.77
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet (2007) 5.74